Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Curcumin × CNS × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Thoracic 1 Gynecologic 1 Genitourinary 1 CNS 1

Conditions

Neurofibromatosis 1 1

Interventions

Temozolomide 127 Radiotherapy 78 Cyclophosphamide 47 Radiation 38 Magnetic Resonance Spectroscopy 35 Bevacizumab 33 Filgrastim 27 Irinotecan 26 Radiosurgery 25 Specimen Handling 20 Carboplatin 20 Topotecan 19 Nivolumab 19 Etoposide 19 pembrolizumab 18 fludarabine 18 Melphalan 17 Surgical Procedures, Operative 16 Granulocyte Colony-Stimulating Factor 16 Vorinostat 15 Vincristine 14 sargramostim 12 Peripheral Blood Stem Cell Transplantation 12 Drug Therapy 12 Busulfan 12 Radiotherapy, Intensity-Modulated 11 O(6)-benzylguanine 11 Everolimus 11 temsirolimus 10 Sorafenib 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05363267 2026-01-13

NF-1, Nutraceutical Intervention

Masonic Cancer Center, University of Minnesota

Phase 1 Active not recruiting

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡